Patent abuse driving high drug prices, non-profit claims

02-08-2018

Patent abuse driving high drug prices, non-profit claims

Xesai / iStockphoto.com

Aggressive and exploitative patenting strategies are enabling drug makers to regularly increase prices in the US and extend monopolies, according to a new report from non-profit group the Initiative for Medicines, Access and Knowledge (I-MAK).


I-MAK, patent abuse, generics, high drug prices, patent protection, monopoly, AbbVie, Roche, Genentech, evergreening

More on this story

PTAB shoots down tenth I-MAK Gilead challenge
24-07-2018

LSIPR